Modern myopia management continues to evolve with off-label and pipeline pharmaceuticals, FDA-approved spectacle lens designs, soft contact lenses and Ortho-K options, and light-based therapies. Join this expert panel to discuss the genetics behind syndromic high myopia, how fascinating color vision research is progressing and impacting myopia management, and the myriad of options available to prevent, control, and potentially one day reverse myopia.